167 related articles for article (PubMed ID: 37476329)
21. Corrigendum to: Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.
Neurooncol Adv; 2023; 5(1):vdad114. PubMed ID: 37750101
[TBL] [Abstract][Full Text] [Related]
22. Advances in the classification of pediatric brain tumors through DNA methylation profiling: From research tool to frontline diagnostic.
Kumar R; Liu APY; Orr BA; Northcott PA; Robinson GW
Cancer; 2018 Nov; 124(21):4168-4180. PubMed ID: 30255939
[TBL] [Abstract][Full Text] [Related]
23. Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case Series.
Bächli H; Ecker J; van Tilburg C; Sturm D; Selt F; Sahm F; Koelsche C; Grund K; Sutter C; Pietsch T; Witt H; Herold-Mende C; von Deimling A; Jones D; Pfister S; Witt O; Milde T
Klin Padiatr; 2018 Oct; 230(6):305-313. PubMed ID: 29996150
[TBL] [Abstract][Full Text] [Related]
24. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
[No Abstract] [Full Text] [Related]
25. Comprehensive study of semi-supervised learning for DNA methylation-based supervised classification of central nervous system tumors.
Tran QT; Alom MZ; Orr BA
BMC Bioinformatics; 2022 Jun; 23(1):223. PubMed ID: 35676649
[TBL] [Abstract][Full Text] [Related]
26. Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patients.
Diaz Coronado RY; Mynarek M; Koelsche C; Mora Alferez P; Casavilca Zambrano S; Wachtel Aptowitzer A; Sahm F; von Deimling A; Schüller U; Spohn M; Sturm D; Pfister SM; Morales La Madrid A; Sernaque Quintana R; Sarria Bardales G; Negreiros Chinchihuara T; Ojeda Medina L; Garcia-Corrochano Medina P; Campos Sanchez DA; Ponce Farfan J; Rutkowski S; Garcia Leon JL
Cancer; 2022 Feb; 128(4):697-707. PubMed ID: 34674226
[TBL] [Abstract][Full Text] [Related]
27. Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.
Wu Z; Abdullaev Z; Pratt D; Chung HJ; Skarshaug S; Zgonc V; Perry C; Pack S; Saidkhodjaeva L; Nagaraj S; Tyagi M; Gangalapudi V; Valdez K; Turakulov R; Xi L; Raffeld M; Papanicolau-Sengos A; O'Donnell K; Newford M; Gilbert MR; Sahm F; Suwala AK; von Deimling A; Mamatjan Y; Karimi S; Nassiri F; Zadeh G; Ruppin E; Quezado M; Aldape K
Neuro Oncol; 2022 Apr; 24(4):571-581. PubMed ID: 34555175
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological and molecular characterization of a case classified by DNA‑methylation profiling as "CNS embryonal tumor with BRD4-LEUTX fusion".
Lebrun L; Allard-Demoustiez S; Gilis N; Van Campenhout C; Rodesch M; Roman C; Calò P; Lolli V; David P; Fricx C; De Witte O; Escande F; Maurage CA; Salmon I
Acta Neuropathol Commun; 2023 Mar; 11(1):46. PubMed ID: 36934287
[TBL] [Abstract][Full Text] [Related]
29. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact.
Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M
Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158
[TBL] [Abstract][Full Text] [Related]
30. Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping.
Lyon JF; Vasudevaraja V; Mirchia K; Walker JM; Corona RJ; Chin LS; Tran I; Snuderl M; Richardson TE; Viapiano MS
Acta Neuropathol Commun; 2021 Jun; 9(1):120. PubMed ID: 34193272
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of histopathological ependymoma variants.
Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of DNA Methylation Array for Glioma Tumor Profiling and Description of a Novel Epi-Signature to Distinguish IDH1/IDH2 Mutant and Wild-Type Tumors.
Schenkel LC; Mathew J; Hirte H; Provias J; Paré G; Chong M; Grafodatskaya D; McCready E
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360312
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation provides diagnostic value for meningioma recurrence in clinical practice.
Shen E; Leclair NK; Herlth K; Soucy M; Renzette N; Zhuo X; Kelly K; Omerza G; Onyiuke H; McNeill I; Wolansky L; Becker K; Li L; Wu Q; Bulsara KR
Acta Neurochir (Wien); 2023 May; 165(5):1323-1331. PubMed ID: 36920663
[TBL] [Abstract][Full Text] [Related]
34. [The 2021 WHO classification of tumours of the central nervous system].
Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
[TBL] [Abstract][Full Text] [Related]
35. Role of DNA Methylation Profile in Diagnosing Astroblastoma: A Case Report and Literature Review.
Petruzzellis G; Alessi I; Colafati GS; Diomedi-Camassei F; Ciolfi A; Pedace L; Cacchione A; Carai A; Tartaglia M; Mastronuzzi A; Miele E
Front Genet; 2019; 10():391. PubMed ID: 31114608
[TBL] [Abstract][Full Text] [Related]
36. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of neuropathology in the management of progressive glioblastoma in adults.
Goodman AL; Velázquez Vega JE; Glenn C; Olson JJ
J Neurooncol; 2022 Jun; 158(2):179-224. PubMed ID: 35648306
[TBL] [Abstract][Full Text] [Related]
37. Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma.
Li R; Shui L; Jia J; Wu C
Front Genet; 2020; 11():906. PubMed ID: 32922438
[TBL] [Abstract][Full Text] [Related]
38. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
[TBL] [Abstract][Full Text] [Related]
39. Decoding the DNA methylome of central nervous system tumors: An emerging modality for integrated diagnosis.
Satomi K; Ichimura K; Shibahara J
Pathol Int; 2024 Feb; 74(2):51-67. PubMed ID: 38224248
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation-based diagnosis confirmation in a pediatric patient with low-grade glioma: a case report.
Morgacheva D; Ryzhova M; Zheludkova O; Belogurova M; Dinikina Y
Front Pediatr; 2023; 11():1256876. PubMed ID: 37818165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
